New drug duo enters fight against Tough-to-Treat cancers
NCT ID NCT06341114
Summary
This study is testing a new combination of two drugs, BAT8008 and BAT1308, for people with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest and most effective dose and to see if the combination can help shrink or control tumors. The trial will enroll about 112 adults with various advanced cancers, including triple-negative breast cancer, lung cancer, and others.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Song ZhengBo
Hangzhou, Zhejiang, 310005, China
Conditions
Explore the condition pages connected to this study.